Haverford Healthcare Advisors
Haverford Healthcare Advisors is a specialized financial consulting firm offering transaction advisory, business valuation, and outsourced acquisition services for healthcare services companies and specialty physician practices.
What stands out about Haverford Healthcare Advisors
Haverford Healthcare Advisors publicly describes a healthcare-focused advisory model covering sell-side transaction support, business valuation, and outsourced acquisition services. It states that typical transaction values range from $5 million to $250 million and that clients are located throughout the United States.[1][2][3][4][5]
What does Haverford Healthcare Advisors do?
Haverford Healthcare Advisors is a specialized financial consulting firm dedicated to transaction advisory and business valuation services for healthcare services companies. Its public offerings also include outsourced acquisition services. The firm’s official contact address is in Radnor, Pennsylvania.[1][2] Haverford publicly offers transaction advisory, business valuation, and outsourced acquisition services. Its transaction-advisory process includes owner education, objective-setting, marketing strategy, confidential information memorandum preparation, valuation, buyer identification, proposal evaluation, due diligence, negotiation, and closing support. Its outsourced acquisition services include acquisition-criteria development, target identification, preliminary diligence and valuation, LOI negotiation, diligence coordination, and definitive-agreement support.[2][3][4]Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.
Published criteria: Haverford states that transaction values typically range from $5 million to $250 million and that it works with specialty physician practices and healthcare services companies of all sizes.[3]
What should a business owner evaluate before hiring Haverford Healthcare Advisors?
For an owner evaluating Haverford, the stated healthcare specialization, transaction-advisory process, valuation capability, nationwide client coverage, and $5 million to $250 million typical transaction-value range provide specific points for discussion. Owners should clarify which completed transactions are comparable by specialty, geography, size, and ownership structure; how buyer identification and qualification would apply to the engagement; and which legal entity would contract for the work. The official transaction-advisory page does not publish a standard advisory-fee percentage, minimum fee, expense schedule, termination fee, or tail-period schedule, so those terms should be requested directly.[3][6]Which completed transactions are comparable by specialty, geography, transaction size, and ownership structure
What are the advisory fee, expense, termination, exclusivity, and tail provisions for the proposed engagement
Which legal entity would contract for the engagement, and how does Haverford Healthcare Advisors relate to Haverford Capital Advisors, Inc.
What size transactions and clients does Haverford Healthcare Advisors focus on?
Haverford publicly focuses on healthcare services companies and specialty physician practices. Examples identified in its public materials include clinical laboratories, diagnostic imaging centers, pathology, anesthesiology, and radiology practices.[3] Haverford’s official transactions page lists completed examples on which it served as sell-side advisor, including Spokane, Washington AP lab assets sold to a Burlington, North Carolina buyer; Spokane, Washington clinical lab assets sold to a Burlington, North Carolina buyer; a Los Angeles, California healthcare business acquired by a Lake Forest, California buyer; and North Platte, Nebraska select assets sold to a Pendleton, Oregon buyer. Haverford also states that it served as Aurora Diagnostics’ outsourced business-development team and sourced 36 pathology-practice acquisitions from 2006 through 2018. The related page states that Aurora Diagnostics was acquired by Sonic Healthcare Ltd. for $540 million on January 31, 2019.[4][5] Haverford describes transaction advisory for healthcare owners and outsourced acquisition support for acquisitive clients. It states that typical transaction values range from $5 million to $250 million and that it works with healthcare companies of all sizes.[3][4]What does Haverford Healthcare Advisors publicly disclose about fees, process and engagement terms?
The official transactions page identifies completed transactions and aggregate transaction statistics but does not disclose transaction dates, consideration terms, or individual transaction values for the listed examples. The official transaction-advisory page does not publish a standard advisory-fee percentage, minimum fee, expense schedule, termination fee, or tail-period schedule.[3][5] An official Haverford company-overview document identifies Haverford Healthcare Advisors as a division of Haverford Capital Advisors, Inc.[6] Haverford states that its transaction-advisory process helps owners understand what a transaction with a national consolidator or private equity firm means for the owner and partners. The stated process includes buyer identification and qualification, proposal evaluation, due diligence, negotiation, and closing support.[3]Questions to ask before hiring Haverford Healthcare Advisors
Which completed transactions are comparable by specialty, geography, transaction size, and ownership structure?
What are the advisory fee, expense, termination, exclusivity, and tail provisions for the proposed engagement?
Which legal entity would contract for the engagement, and how does Haverford Healthcare Advisors relate to Haverford Capital Advisors, Inc.?
How would buyer identification, qualification, confidentiality, proposal evaluation, diligence, negotiation, and closing support be handled for the engagement?
How would the engagement address a transaction involving a national consolidator or private equity firm?
Sources & research notes
- Official website / firm overview
- Services / capabilities
- Services / capabilities
- Services / capabilities
- Transaction / portfolio evidence
- Structure / regulatory context
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.